Live feed07:52:35·434dANALYSTRatingvia QuantisnowNeurocrine Biosciences upgraded by Needham with a new price targetByQuantisnow·Wall Street's wire, on your screen.NBIX· Neurocrine Biosciences Inc.Health CareOriginal source